Kiniksa Pharmaceuticals International (KNSA) Earnings (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) earnings from Jun 30, 2017 to Mar 31, 2026. The TTM Kiniksa Pharmaceuticals International (KNSA) earnings is $73M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Kiniksa Pharmaceuticals International (KNSA) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -28.07% |
Annual Earnings change of Kiniksa Pharmaceuticals International (KNSA)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $23M | -61.72% |
| 2025 | $59M | -236.63% |
| 2024 | -$43M | -406.75% |
| 2023 | $14M | -92.32% |
| 2022 | $183M | -216.11% |
| 2021 | -$158M | -2.14% |
| 2020 | -$161M | -0.30% |
| 2019 | -$162M | +56.81% |
| 2018 | -$103M | +59.13% |
| 2017 | -$65M | N/A |